title: Targeted doxorubicin-liposomes as a tool to circumvent P-gp-mediated resistance in ovarian carcinoma cells.
authors.affiliation: Department of Pharmacy, University of Bonn, Bonn, Germany. mkrieger@uni-bonn.de
authors.forename: M L
authors.initials: ML
authors.lastname: Krieger
authors.forename: A
authors.initials: A
authors.lastname: Konold
authors.forename: M
authors.initials: M
authors.lastname: Wiese
authors.forename: U
authors.initials: U
authors.lastname: Jaehde
authors.forename: G
authors.initials: G
authors.lastname: Bendas
mesh_terms: D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1 / Q000502:physiology*; D045744:Cell Line, Tumor; D004317:Doxorubicin / Q000008:administration & dosage*; D019008:Drug Resistance, Neoplasm; D005260:Female; D006801:Humans; D008081:Liposomes; D010051:Ovarian Neoplasms / Q000188:drug therapy*
chemical_list: D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1; D008081:Liposomes; D004317:Doxorubicin